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Background: An increased leukocyte count is an independent risk factor for cardiovascular events, but the
association between leukocyte subtype counts and carotid atherosclerosis in patients with diabetes has not been
determined. We therefore investigated the correlation between leukocyte subtype counts and intima-media
thickness of the common carotid artery (CCA-IMT) in subjects with type 2 diabetes.
Methods: This cross-sectional study involved 484 in-patients with type 2 diabetes (282 males and 202 females),
who were hospitalized for glycemic control and underwent carotid ultrasonography at Kumamoto University
Hospital between 2005 and 2011. Mean and maximum CCA-IMT was measured by high-resolution B-mode
ultrasonography.
Results: Univariate analyses revealed that mean CCA-IMT was positively correlated with age, systolic blood pressure,
brachial-ankle pulse wave velocity (PWV), urinary albumin excretion and duration of diabetes, but was negatively
correlated with diastolic blood pressure and fasting plasma glucose. Maximum CCA-IMT was positively and
negatively correlated with the same factors as mean CCA-IMT except for fasting plasma glucose. Mean CCA-IMT
was positively correlated with total leukocyte (r = 0.124, p = 0.007), monocyte (r = 0.373, p < 0.001), neutrophil
(r = 0.139, p = 0.002) and eosinophil (r = 0.107, p = 0.019) counts. Maximum CCA-IMT was positively correlated with
total leukocyte (r = 0.154, p < 0.001), monocyte (r = 0.398, p < 0.001), neutrophil (r = 0.152, p < 0.001) and basophil
counts (r = 0.102, p = 0.027). Multiple regression analyses showed that monocyte count, age and PWV were signifi-
cant and independent factors associated with mean CCA-IMT (adjusted R2 = 0.239, p < 0.001), and that monocyte
count, age and urinary albumin excretion were significant and independent factors associated with maximum
CCA-IMT (adjusted R2 = 0.277, p < 0.001).
Conclusions: Monocyte counts were positively correlated with both mean CCA-IMT and maximum CCA-IMT in
patients with type 2 diabetes. Monocyte count may be a useful predictor of macrovascular complications in patients
with type 2 diabetes.
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Table 1 Subject characteristics (n = 484)
Age (years) 59.7 ± 12.6
Sex (% male) 58.3
Duration of diabetes (years) 13.2 ± 10.2
BMI (kg/m2) 26.1 ± 11.4
SBP (mmHg) 129.7 ± 20.5
DBP (mmHg) 75.5 ± 12.7
FPG (mmol/l) 9.0 ± 3.2
HbA1c (%) 9.1 ± 2.1
TC (mmol/l) 5.21 ± 1.30
TG (mmol/l) 1.91 ± 1.50
HDL cholesterol (mmol/l) 1.28 ± 0.38
LDL cholesterol (mmol/l) 3.06 ± 1.05
non-HDL cholesterol (mmol/l) 3.93 ± 1.30
hs-CRP (mg/l) 0.22 ± 0.41
mean-CCA-IMT (mm) 0.97 ± 0.38
max-CCA-IMT (mm) 1.11 ± 0.53
baPWV (cm/s) 1748.4 ± 360.0
UAE (mg/day) 363.1 ± 891.6
total leukocyte count (/mm3) 6258.1 ± 1656.8
Monocyte count (/mm3) 340.5 ± 106.5
Neutrophil count (/mm3) 3587.2 ± 1232.6
Lymphocyte count (/mm3) 2079.5 ± 680.4
Eosinophil count (/mm3) 208.1 ± 145.5
Basophil count (/mm3) 32.2 ± 25.9







Cardiovascular disease (%) 18.8
Diabetes medication (%)
Oral hypoglycemic agents 50.0
Insulin 28.3
Oral hypoglycemic agents + insulin 7.6
Statins (%) 22.3
ARBs and/or ACEIs (%) 29.8
CCBs (%) 29.5
Ant-platelet agents (%) 17.1
Data are means ± SD.
SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma
glucose; TC, total cholesterol; TG, triglyceride; hs-CRP, high sensitive C-reactive
protein; CCA-IMT, intima-media thickness of common carotid artery; baPWV,
brachial ankle pulse wave velocity; UAE, urinary albumin excretion; ARBs,
angiotensin II receptor blockers; ACEIs, angiotensin converting enzymes; CCBs,
calcium channel blockers.
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Type 2 diabetes mellitus is associated with a high risk of
cardiovascular diseases (CVD), and many patients with
diabetes die from CVD, mainly caused by markedly ad-
vanced atherosclerosis [1]. Measurement of the intima-
media thickness of the common carotid artery (CCA-
IMT) by B-mode ultrasound was found suitable for
monitoring the early stages of atherosclerosis [2]. More-
over, CCA-IMT has been reported to be an indicator of
CVD [3,4]. On the other hand, increased CCA-IMT has
also been observed in patients with type 2 diabetes [5-7]
or metabolic syndrome [8], and asymptomatic hypergly-
cemic subjects were shown to have significantly higher
CCA-IMT than healthy control subjects [9]. Therefore,
CCA-IMT has been used as a marker of atherosclerosis
progression in patients with type 2 diabetes.
Atherosclerosis is a chronic inflammatory process
characterized by early leukocyte recruitment and pro-
gression to atherosclerotic plaque maturation [10]. Sev-
eral epidemiologic studies have reported that an
increased leukocyte count is a strong and independent
risk factor for cardiovascular events [11-17] and for the
prevalence and progression of subclinical carotid athero-
sclerosis [18-23]. However, Kuo et al. reported no associ-
ation between total leukocyte count and CCA-IMT in
asymptomatic subjects with abnormal complete blood
cells in Taiwan [24]. On the other hand, the associations
between leukocyte subtype counts and carotid athero-
sclerosis in patients with diabetes are largely unknown.
Thus, this study was designed to investigate the associa-
tions between leukocyte subtype counts and carotid




This cross-sectional study recruited 562 patients with
type 2 diabetes who were hospitalized for glycemic
control and underwent carotid ultrasonography at
Kumamoto University Hospital between 2005 and 2011.
Type 2 diabetes was diagnosed based on World Health
Organization criteria [25]. Patients with type 1 diabetes
were excluded, as were patients positive for glutamic
acid decarboxylase antibody, those with a history of
ketoacidosis, and patients dependent on insulin therapy
for survival. Patients with severe hepatic disease, malig-
nancy, or acute/chronic inflammatory disease were also
excluded. A total of 484 subjects with type 2 diabetes
(282 men, and 202 women) were analyzed. Patient char-
acteristics are listed in Table 1. All subjects included in
this study were Japanese. Each patient participated in a
detailed interview of his/her personal disease and smok-
ing history. Information on smoking habits was assessed
by a standardized questionnaire. Smoking status of
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smoker (ceased smoking for at least 1 year), or current
smoker. In this study, former and current smokers were
pooled and compared with never smokers.
Hypertension was defined by a blood pressure > 130/
80 mmHg or treatment with antihypertensive agents.
Hyperlipidemia was defined as TC > 5.7 mmol/l and/or
TG > 1.7 mmol/l or treatment with antihyperlipidemic
agents. Cardiovascular disease was defined as stroke, is-
chemic heart disease and arteriosclerosis obliterans.
The study protocol was approved by the Human Eth-
ics Review Committee of Kumamoto University (Proto-
col Number: 1171), and all subjects provided written
informed consent.
Laboratory measurements
Within 2 days of admission, blood samples were col-
lected from all participants in the early morning after an
overnight fast. An automated hematologic analyzer (XE-
2100, Sysmex, Kobe, Japan) was used to measure total
and differential leukocyte counts. Fasting plasma glucose
(FPG), high-sensitivity C-reactive protein (hs-CRP), gly-
cosylated hemoglobin (HbA1c), serum total cholesterol
(TC), triglycerides (TG) and high-density lipoprotein
(HDL) cholesterol were measured by standard methods.
Low-density lipoprotein (LDL) cholesterol was deter-
mined using the Friedewald formula [26]. Non-HDL
cholesterol was calculated by subtracting HDL choles-
terol from TC. HbA1c (%) was estimated as National
Glycohemoglobin Standardization Program (NGSP)
equivalent values (%), calculated using the formula
HbA1c (%) = 1.02 × HbA1c [Japan Diabetes Society
(JDS)] (%) + 0.25%, considering the relational expression
of HbA1c (JDS) (%) measured by the previous Japanese
standard substance and measurement methods and
HbA1c (NGSP) [27]. Urinary albumin excretion (UAE)
was assessed and performed in three consecutive 24 h
urinary collections. For collection of the urine sample, a
3-liter plastic container was used, and the volume of
total urine was measured. Albumin levels were deter-
mined by standard immunonephelometric assay. UAE
was expressed as milligrams per 24 h of the mean of
three measures.
Carotid ultrasonography and brachial-ankle pulse wave
velocity (baPWV) measurement
IMT was measured ultrasonographically using the
Shimadzu SDU-2200 (Shimadzu Co., Ltd, Kyoto, Japan)
at a transducer frequency of 5–10 MHz. This system
provides an axial resolution of 0.30 mm. Intima Scope
software (Media Cross Co. Ltd, Tokyo, Japan) was used
for computer-assisted acquisition, processing, storage of
B-mode images, and calculation of IMT. The near and
far walls of the common carotid arteries, the carotidbifurcations, and the origins (first 2 cm) of the internal
carotid arteries were scanned longitudinally and trans-
versely to assess the occurrence of plaques. IMT was de-
fined and measured as previously described [2]. We used
the scans of the far wall CCAs for mean IMT, because
several methodological reviews [28-30] have reported
that i) IMT can only be measured accurately in the far
wall position, and ii) multiple, good-quality scans may
be obtained from nearly every patient from the CCAs,
while the percentage of missing images from the internal
carotid arteries is higher. The mean values of CCA-IMT
(mean-CCA-IMT) and maximum values of CCA-IMT
(max-CCA-IMT) were used in this study.
All carotid artery measurements were performed by
three sonographers, who, at the time of examination,
were unaware of detailed clinical information on each
patient. Mean-CCA-IMT was measured using an auto-
mated edge-detection algorithm based on significant
changes in density of a section between the lumen and
subadventitial structures perpendicular to the vessel
wall. The software estimated lines for the lumen-intima
interface and the media-adventitia interface based on
30-point pixels per 3 mm from tertiary multiple regres-
sion analysis incorporating the least squares method,
which was designed to increase accuracy and reproduci-
bility while reducing variability for measurements of
IMT. Using longitudinal views of both the right and left
CCAs, two measurements were made at the 20 mm seg-
ment distal to the carotid bulbs. For each measurement
the average values were calculated automatically. Sono-
graphers repeated ultrasound examinations in 42 sub-
jects to ensure the reproducibility of the measurements.
The correlation coefficients for the intra- and interob-
server variations were 0.91 (p < 0.001) and 0.89 (p <
0.001), respectively, for mean-CCA-IMT, and were 0.89
(p < 0.001) and 0.83 (p < 0.001), respectively, for max-
CCA-IMT.
Systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) were measured twice with the patient in a
sitting position after a 5-min rest. Left and right baPWV
were measured automatically using an ABI-form (BP-
203RPE II; Nippon Colin, Komaki, Japan). The highest
values of SBP, DBP and baPWV from the left and the
right sides were used in this study. Regarding reproduci-
bility, the coefficient of variation was less than 5% for
baPWV [31].
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware version 14 for Windows (SPSS Inc., Chicago, IL,
USA). All data are given as means ± standard deviation
or as actual numbers. Since some variables showed a
skewed distribution (i.e., mean CCA-IMT, max-CCA-
IMT, duration of diabetes, TG, hs-CRP, UAE, monocyte
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logarithmically transformed before the analysis. The
influences of variables on several factors including
mean-CCA-IMT, max-CCA-IMT, total leukocyte count,
monocyte count and neutrophil count were explored by
simple linear analysis, using Pearson’s method for con-
tinuous variables. An unpaired Student t-test was used
for normally distributed variables. For the multivariate
analysis, stepwise linear regression was performed. The
criteria for entering or keeping the variable in the model
were p < 0.05 and p < 0.1, respectively, in the univariate
analysis. In the case of collinear and conceptually inter-
twined variables (such as TC and LDL cholesterol, or
HbA1c and FPG), alternative models were constructed.
Finally, factors included in the stepwise multiple regres-
sion models for mean-CCA-IMT were age, sex, duration
of diabetes, body mass index (BMI), SBP, FPG, baPWV,
UAE, total leukocyte count, monocyte count, neutrophil
count, eosinophil count and basophil count. Factors for
max-CCA-IMT were age, sex, duration of diabetes,
smoking status, BMI, SBP, baPWV, UAE, total leukocyte
count, monocyte count, neutrophil count, eosinophil
count and basophil count. A p value < 0.05 was consid-
ered statistically significant.
Results
The characteristics of the study subjects are shown in
Table 1. Mean age was 59.7 ± 12.6 years, and 58.3% of
the subjects were male. The mean duration of diabetes
was 13.2 ± 10.2 years, and the mean HbA1c was 9.1 ±
2.1%. Mean CCA-IMT, max-CCA-IMT and baPWV
were 0.97 ± 0.38 mm, 1.11 ± 0.53 mm and 1748.4 ±
360.0 cm/s, respectively. The total leukocyte, monocyte,
neutrophil, lymphocyte, eosinophil and basophil counts
were 6258.1 ± 1656.8/mm3, 340.5 ± 106.5/mm3, 3587.2 ±
1232.6/mm3, 2079.5 ± 680.4/mm3, 208.1 ± 145.5/mm3
and 32.2 ± 25.9/mm3, respectively. Overall, 18.8% of the
patients had a history of myocardial infarction and/or
stroke.
Univariate associations of mean-CCA-IMT and max-
CCA-IMT with the clinical characteristics in the patients
are shown in Table 2. Mean-CCA-IMT was positively
correlated with age, duration of diabetes, BMI, baPWV,
UAE and SBP, but negatively correlated with DBP and
FPG (Table 2). Max-CCA-IMT showed similar correla-
tions except for FPG (Table 2). Additional analyses were
performed to determine the associations of leukocyte
subset counts with mean-CCA-IMT or max-CCA-IMT
in patients with type 2 diabetes (Table 2, Figures 1 and 2).
Mean-CCA-IMT was positively correlated with total
leukocyte, monocyte, neutrophil and eosinophil counts
(Table 2). Max-CCA-IMT was positively correlated with
total leukocyte, monocyte, neutrophil and basophil
counts (Table 2). Both mean-CCA-IMT and max-CCA-IMT in males were significantly higher than in females
(p = 0.015 and p = 0.006, respectively.). On the other
hand, smoking was significantly associated with in-
creased max-CCA-IMT (p = 0.007), but not with mean-
CCA-IMT (p = 0.16).
We analyzed the univariate associations of total
leukocyte, monocyte and neutrophil counts with the
clinical characteristics of the patients with type 2 dia-
betes (Table 3). Total leukocyte count was positively cor-
related with BMI, SBP, DBP, TC, TG, LDL cholesterol,
non-HDL cholesterol, hs-CRP, mean-CCA-IMT, max-
CCA-IMT and UAE, but negatively correlated with age
and HDL cholesterol (Table 3). The monocyte count
was positively correlated with duration of diabetes, SBP,
TC, TG, LDL cholesterol, hs-CRP, mean-CCA-IMT,
max-CCA-IMT and UAE, and negatively correlated with
HDL cholesterol (Table 3). The neutrophil count was
positively correlated with BMI, SBP, DBP, TC, TG, non-
HDL cholesterol, hs-CRP, mean-CCA-IMT, max-CCA-
IMT and UAE, and negatively correlated with age and
HDL cholesterol (Table 3). The monocyte count in
males was significantly higher than that in females (p <
0.001). Smoking was significantly associated with an in-
creased monocyte count (p < 0.001).
We next performed stepwise multiple regression ana-
lysis to identify the independent factors associated
with mean-CCA-IMT and max-CCA-IMT (Table 4).
Monocyte count, age and baPWV were significant and
independent factors associated with mean-CCA-IMT
(adjusted R2 = 0.239, p < 0.001). On the other hand,
monocyte count, age and UAE were significant and in-
dependent factors associated with max-CCA-IMT (ad-
justed R2 = 0.277, p < 0.001) (Table 4).
Discussion
Several studies have reported that CCA-IMT is a useful
marker for the progression of atherosclerosis in subjects
with type 2 diabetes [3-5,32,33]. Here, we revealed that
age, duration of diabetes, SBP and DBP were correlated
with mean-CCA-IMT and max-CCA-IMT in Japanese
patients with type 2 diabetes. Interestingly, we also
found, for the first time, that total leukocyte count and
its components (i.e., monocyte, neutrophil, eosinophil
and basophil counts) were correlated with carotid-IMT
in these patients.
Monocytes and monocyte-derived macrophages play
important roles in atherosclerotic plaque progression.
For example, a high monocyte count in healthy, middle-
aged men was found to be predictive of coronary events
[34]. In that study, the rate of coronary events was
higher in subjects with a high (> 500/mm3) than a low
(≤ 500/mm3) monocyte count [27], suggesting that a
higher monocyte count may contribute to the state of
atherosclerosis. Moreover, the baseline monocyte count
Table 2 Correlation analysis of mean-CCA-IMT and max-CCA-IMT with metabolic parameters
mean-CCA-IMT max-CCA-IMT
r p r p
Age 0.327 <0.001 Age 0.343 <0.001
Duration of diabetes 0.262 <0.001 Duration of diabetes 0.237 <0.001
BMI −0.169 <0.001 BMI −0.151 <0.001
FPG −0.095 0.043 FPG −0.044 0.35
HbA1c −0.053 0.25 HbA1c −0.011 0.81
TC −0.038 0.42 TC −0.038 0.41
TG −0.010 0.83 TG −0.022 0.64
HDL-C −0.017 0.72 HDL-C −0.021 0.65
LDL-C −0.031 0.5 LDL-C −0.016 0.74
non-HDL-C −0.032 0.49 non-HDL-C −0.032 0.49
hs-CRP 0.029 0.54 hs-CRP 0.000 0.99
max-CCA-IMT 0.798 <0.001 mean-CCA-IMT 0.798 <0.001
baPWV 0.292 <0.001 baPWV 0.286 <0.001
UAE 0.109 0.018 Urinary albumin 0.151 <0.001
SBP 0.145 0.002 SBP 0.135 0.003
DBP −0.104 0.024 DBP −0.092 0.045
Total leukocyte count 0.124 0.007 Total leukocyte count 0.154 <0.001
Monocyte count 0.373 <0.001 Monocyte count 0.398 <0.001
Neutrophil count 0.139 0.002 Neutrophil count 0.152 <0.001
Lymphocyte count −0.025 0.59 Lymphocyte count 0.019 0.68
Eosinophil count 0.107 0.019 Eosinophil count 0.077 0.093
Basophil count 0.083 0.072 Basophil count 0.102 0.027
Data are means ± SD.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high-
density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; hs-CRP, high sensitive C-reactive protein; CCA-IMT, intima-media thickness of common
carotid artery; baPWV, brachial ankle pulse wave velocity; UAE, urinary albumin excretion. Since mean CCA-IMT, max-CCA-IMT, Duration of diabetes, TG, hs-CRP,
UAE, Monocyte count, Eosinophil count and Basophil count showed skewed distribution, it was logarithmically transformed before the analysis.
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have coronary events (365 ± 366 vs. 227 ± 197/mm3, p <
0.001) [34]. The monocyte count has also been reported
to be an independent predictor of common carotid ath-
erosclerosis in healthy subjects [18], and a high mono-
cyte count (≥ 800/mm3) during the acute phase of acute
myocardial infarction was associated with plaque pro-
gression [19]. We found that, among the leukocyte frac-
tions, the monocyte count showed the strongest
correlation with mean-CCA-IMT and max-CCA-IMT.
Stepwise multiple regression analysis confirmed that the
monocyte count was an independent predictor of both
mean-CCA-IMT and max-CCA-IMT. Moreover, since
the correlation coefficient of max-CCA-IMT was higher
than that of mean-CCA-IMT, the monocyte count may
be useful as a clinical predictor of diabetic macroangio-
pathy, especially carotid plaque, as represented by max-
CCA-IMT.
Previous studies have reported that not only macro-
phages but also neutrophils are observed in theatherosclerotic plaque lesion [35]. Thus, it is recognized
that neutrophils could be involved, at least in part, in
atherosclerotic plaque progression. Although the neutro-
phil count was positively associated with mean-CCA-
IMT and max-CCA-IMT in the present study, the cor-
relation coefficients of these factors were lower than
those of the monocyte count. Therefore, the involve-
ment of neutrophils may be weaker than that of
monocyte-macrophages in plaque formation in athero-
sclerosis. On the other hand, the correlation coefficients
of the total leukocyte count with mean-CCA-IMT and
max-CCA-IMT were also lower than those of the mono-
cyte count. The total leukocyte count includes not only
monocytes or neutrophils but also other non- or weak-
associated cells, such as lymphocytes, eosinophils and
basophils. Thus, the association of the total leukocyte
count may be lower than that of the monocyte count.
These results suggested that among the leukocyte sub-
types, the monocyte count was the most useful marker




































































































































Log-mean-CCA-IMT (a.u.) Log-mean-CCA-IMT (a.u.)
Log-mean-CCA-IMT (a.u.) Log-mean-CCA-IMT (a.u.)
Figure 1 Association of leukocyte subset counts with mean-CCA-IMT in patients with type 2 diabetes. A, total leukocyte count;
B, monocyte count; C, neutrophil count; D, lymphocyte count; E, eosinophil count; F, basophil count. Since mean-CCA-IMT, monocyte count,
eosinophil count and basophil count showed skewed distribution, data were logarithmically transformed before the analysis. a.u., arbitrary unit.
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with age, it never exceeded 1.1 mm in normal subjects
[2,5]. Moreover, the prevalence of coronary heart disease
in patients with type 2 diabetes was found to be signifi-
cantly higher in patients with CCA-IMT ≥ 1.1 mm than
< 1.1 mm [9]. Therefore, a CCA-IMT of 1.1 mm is usu-
ally accepted as a cut-off value for the presence of
carotid atherosclerosis in patients with type 2 diabetes.
We observed a positive linear correlation between
monocyte count and CCA-IMT, with a monocyte countof 353/mm3 corresponding to a CCA-IMT of 1.1 mm in
Japanese patients with type 2 diabetes.
In the present study, baPWV was not correlated with
monocyte count. There are no reports of an association be-
tween baPWV and monocyte count. In general, increased
IMT is thought to represent one of the earliest stages of
atherosclerosis [36]. On the other hand, arterial stiffness is
suggested to be a useful marker of the extent of atheroscler-
osis in the aorta [37]. Therefore, monocyte count may be a
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Log-max-CCA-IMT (a.u.) Log-max-CCA-IMT (a.u.)
Log-max-CCA-IMT (a.u.) Log-max-CCA-IMT (a.u.)
Figure 2 Association of leukocyte subset counts with max-CCA-IMT in patients with type 2 diabetes. A, total leukocyte count;
B, monocyte count; C, neutrophil count; D, lymphocyte count; E, eosinophil count; F, basophil count. Since max-CCA-IMT, monocyte count,
eosinophil count and basophil count showed skewed distribution, data were logarithmically transformed before the analysis. Units of leukocyte,
neutrophil and lymphocytes were/mm3. a.u., arbitrary unit.
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monocytes and monocyte-derived macrophages playing
pivotal roles in the progression of atherosclerosis [10].
During this progression, the number of monocytes in
blood samples may be affected by pro-inflammatory me-
diators, such as chemokines, cytokines and growth fac-
tors. Macrophage colony-stimulating factor (M-CSF),
which is involved in the proliferation, differentiation and
survival of monocytes, is increased in patients withcoronary artery disease [38-40]. Thus, the association of
monocyte count with CCA-IMT may involve regulation
by several growth factors including M-CSF. In contrast,
monocyte chemoattractant protein-1 (MCP-1) plays a
critical role in the mobilization and infiltration of mono-
cytes, and accelerates atherosclerosis in apoE-deficient
mice [41]. A clinical study found that elevated plasma
MCP-1 levels are associated with an increased risk of
death or myocardial infarction in patients with acute
Table 3 Correlations between total leukocyte, monocyte and neutrophil counts with clinical characteristics
Total leukocyte count Monocyte count Neutrophil count
r p r p r p
Age −0.197 <0.001 −0.007 0.884 −0.115 0.011
Duration of DM 0.006 0.89 0.102 0.025 0.031 0.5
BMI 0.219 <0.001 0.050 0.27 0.161 <0.001
SBP 0.127 0.005 0.126 0.006 0.184 <0.001
DBP 0.113 0.014 0.064 0.16 0.090 0.048
FPG −0.024 0.61 −0.021 0.64 −0.046 0.33
HbA1c 0.083 0.07 0.057 0.21 −0.019 0.68
TC 0.146 0.001 0.036 0.44 0.096 0.038
TG 0.281 <0.001 0.125 0.007 0.163 <0.001
HDL-C −0.171 <0.001 −0.113 0.014 −0.142 0.002
LDL-C 0.132 0.004 0.049 0.29 0.099 0.032
non-HDL-C 0.202 <0.001 0.073 0.12 0.142 0.002
hs-CRP 0.307 <0.001 0.215 <0.001 0.326 <0.001
mean-CCA-IMT 0.124 0.007 0.373 <0.001 0.139 0.002
max-CCA-IMT 0.154 <0.001 0.398 <0.001 0.152 <0.001
baPWV −0.009 0.85 0.072 0.13 0.065 0.16
UAE 0.206 <0.001 0.124 0.007 0.243 <0.001
Data are means ± SD.
SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; hs-CRP, high sensitive C-reactive pro-
tein; CCA-IMT, intima-media thickness of common carotid artery; baPWV, brachial ankle pulse wave velocity; UAE, urinary albumin excretion. Since mean-CCA-IMT,
max-CCA-IMT, duration of diabetes, TG, hs-CRP, UAE, monocyte count, eosinophil count and basophil count showed skewed distribution, it was logarithmically
transformed before the analysis.
Matsumura et al. Cardiovascular Diabetology 2013, 12:177 Page 8 of 10
http://www.cardiab.com/content/12/1/177coronary syndromes [42]. Moreover, MCP-1 transcript
levels are higher in endothelial cells from patients with
than without type 2 diabetes [43]. Therefore, overpro-
duction of MCP-1 may contribute to the positive correl-
ation between monocyte count and CCA-IMT. A recent
study revealed that systemic insulin resistance and sub-
clinical atherosclerosis are associated with decreased in-
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[44]. Therefore, the relationship between monocyte
count and carotid IMT may be correlated with insulin
resistance, and warrants future study.
We also found that the monocyte count in patients
with type 2 diabetes was positively correlated with SBP,
TG, CCA-IMT and hs-CRP, but negatively correlated
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count. Since mean-CCA-IMT, max-CCA-IMT, duration of diabetes, TG, hs-CRP,
ution, it was logarithmically transformed before the analysis.
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http://www.cardiab.com/content/12/1/177subjects with risk factors for CVD, in that monocyte
count was positively correlated with SBP, TG, CCA-IMT
and hs-CRP, and negatively correlated with HDL choles-
terol [18]. Our results also showed that smoking status
was correlated with monocyte count, as in the previous
study [18].
Consistent with previous findings, we observed that
age and duration of diabetes were positively correlated
with CCA-IMT [5]. Although SBP was positively corre-
lated with CCA-IMT, DBP was negatively correlated
with CCA-IMT. Because previous studies have demon-
strated that a combination of increased SBP and de-
creased DBP, representing a wide pulse pressure,
increased carotid IMT in non-diabetic subjects [45,46], a
similar phenomenon may be apparent in our study.
This study had several limitations. First, it was a
single-center cross-sectional study with a relatively small
number of subjects. Thus, further large-scale prospective
studies are needed to confirm the association between
leukocyte subtype counts and diabetic macrovascular
complications. Second, there is no evidence that redu-
cing the number of leukocytes, particularly monocytes,
can prevent macrovascular complications. Indeed, treat-
ment with HMG-CoA reductase inhibitors, which pre-
vent the progression of atherosclerosis, significantly
reduced leukocyte counts without affecting basophil
counts in patients with coronary artery disease [47].
Third, the monocyte count was the only leukocyte type
to be significantly and independently associated with
coronary atherosclerotic progression [36]. Therefore,
further studies are needed to confirm whether a reduc-
tion in the monocyte count is associated with a reduc-
tion in diabetic macrovascular complications. Finally, we
did not determine the effect of pro-inflammatory media-
tors on the relationship between monocyte count and
CCA-IMT. A recent study revealed that the inflamma-
tory status was higher in immune cells in the carotid
plaque, compared that in peripheral blood cells [48].
Further studies are needed to elucidate whether the in-
creased monocyte count is correlated with an increase in
activated monocytes in the carotid plaque, and which
pro-inflammatory cytokines are involved in the increased
monocyte count.
Conclusions
To our knowledge, this study is the first to show that
the numbers of leukocytes, neutrophils and monocytes
were positively correlated with CCA-IMT in patients
with type 2 diabetes. In particular, these results suggest
that monocyte counts may be a useful predictor of dia-
betic macrovascular complications.
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